Metadata
- Name
- Pancreatic Adenocarcinoma Signature Stratification for Treatment
- Repository
- ClinicalTrials.gov
- Identifier
- clinicaltrials:NCT04469556
- Description
- This is a randomized multicentre phase II trial with a large translational component. The
trial will evaluate the two standard chemotherapy regimens: modified folfirinox (mFFX) and
gemcitabine/nab-paclitaxel (GA), in patients with untreated metastatic pancreatic ductal
adenocarcinoma. Integrated into this phase II trial are a number of laboratory components
including molecular profiling, patient derived organoid establishment, and drug testing
sensitivity and other biomarkers. - Data or Study Types
- clinical trial
- Source Organization
- Unknown
- Access Conditions
- available
- Year
- 2020
- Access Hyperlink
- https://clinicaltrials.gov/ct2/show/NCT04469556
Distributions
- Encoding Format: HTML ; URL: https://clinicaltrials.gov/ct2/show/results/NCT04469556